Log in

Khiron Life Sciences Stock Price, Forecast & Analysis (OTCMKTS:KHRNF)

$0.65
0.00 (-0.53 %)
(As of 11/20/2019 08:00 AM ET)
Today's Range
$0.64
Now: $0.65
$0.69
50-Day Range
$0.60
MA: $0.80
$0.94
52-Week Range
$0.59
Now: $0.65
$3.28
Volume297,667 shs
Average Volume283,903 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products. The company was founded in 2017 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:KHRNF
CUSIPN/A
CIKN/A
Phone705-527-3564

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive KHRNF News and Ratings via Email

Sign-up to receive the latest news and ratings for KHRNF and its competitors with MarketBeat's FREE daily newsletter.


Khiron Life Sciences (OTCMKTS:KHRNF) Frequently Asked Questions

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

Has Khiron Life Sciences been receiving favorable news coverage?

News coverage about KHRNF stock has been trending very positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Khiron Life Sciences earned a news sentiment score of 3.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Khiron Life Sciences.

Who are some of Khiron Life Sciences' key competitors?

What other stocks do shareholders of Khiron Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Charlotte's Web (CWBHF), Canopy Growth (CGC), OrganiGram (OGI), Aphria (APHA), KushCo (KSHB), Aurora Cannabis (ACB), Curaleaf (CURLF), Innovative Industrial Properties (IIPR), Emerald Health Therapeutics (EMHTF) and CannaRoyalty (ORHOF).

Who are Khiron Life Sciences' key executives?

Khiron Life Sciences' management team includes the folowing people:
  • Mr. Alvaro Francisco Torres, Founder, CEO & Director (Age 40)
  • Mr. Andres Galofre, Co-founder & VP of Bus. Devel.s (Age 37)
  • Mr. Darren Collins, CFO & Corp. Sec. (Age 36)
  • Dr. Paulo Vega, VP of Medical (Age 54)
  • Mr. Chris Naprawa, Pres (Age 48)

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.65.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is http://www.khiron.ca/.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.


MarketBeat Community Rating for Khiron Life Sciences (OTCMKTS KHRNF)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about Khiron Life Sciences and other stocks. Vote "Outperform" if you believe KHRNF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KHRNF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: Market Indexes

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel